Behavioral animal models of tinnitus, pharmacology, and treatment

Textbook of Tinnitus

Volumn , Issue , 2011, Pages 133-144

  Salvi, Richard ^a   Lobarinas, Edward ^a   Sun, Wei ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Animal models; Drug therapy; Startle reflex; Tinnitus

Indexed keywords

EID: 84871390885     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60761-145-5_16     Document Type: Chapter

References (35)

1. Jastreboff PJ, JF Brennan and CT Sasaki (1988) An animal model for tinnitus. Laryngoscope 98:280-6.
2. Jastreboff PJ (1994) Instrumentation and tinnitus: A neurophysiological approach. Hear Instrum 45:7-11.
3. Hazell J and JB Sheldrake. The Tinnitus and Hyperacusis Centre [website]. [cited 2006 15 April]; Available from: http://www.tinnitus.org.
4. Jastreboff PJ, JF Brennan and CT Sasaki (1991) Quinineinduced tinnitus in rats. Arch Otolaryngol Head Neck Surg 117:1162-6.
5. Londero A, JP Lefaucheur, D Malinvaud et al (2006) Magnetic stimulation of the auditory cortex for disabling tinnitus: Preliminary results. Presse Med 35:200-6.
6. Heffner HE and IA Harrington (2002) Tinnitus in hamsters following exposure to intense sound. Hear Res 170:83-95.
7. Bauer CA, TJ Brozoski, R Rojas et al (1999) Behavioral model of chronic tinnitus in rats. Otolaryngol Head Neck Surg 121:457-62.
8. Guitton MJ, J Caston, J Ruel et al (2003) Salicylate induces tinnitus through activation of cochlear NMDA receptors. J Neurosci 23:3944-52.
9. Ruttiger L, J Ciuffani, HP Zenner et al (2003) A behavioral paradigm to judge acute sodium salicylate-induced sound experience in rats: A new approach for an animal model on tinnitus. Hear Res 180:39-50.
10. Turner JG, (2006) Gap detection as a high throughput, objective behavioral screen for tinnitus, in The future treatment of tinnitus: First Tinnitus Research Initiative meeting 27-29 July 2006. 2006: Regensburg, Salzstadel, Germany.
11. Bauer CA and TJ Brozoski (2001) Assessing tinnitus and prospective tinnitus therapeutics using a psychophysical animal model. J Assoc Res Otolaryngol 2:54-64.
12. Lobarinas E, W Sun, R Cushing et al (2004) A novel behavioral paradigm for assessing tinnitus using schedule-induced polydipsia avoidance conditioning (SIP-AC). Hear Res 190:109-14.
13. Phillips-Howard PA and D Wood (1996) The safety of antimalarial drugs in pregnancy. Drug Saf 14:131-45.
14. Roche RJ, K Silamut, S Pukrittayakamee et al (1990) Quinine induces reversible high-tone hearing loss. Br J Clin Pharmacol 29:780-2.
15. Smilkstein MJ, KW Kulig and BH Rumack (1987) Acute toxic blindness: Unrecognized quinine poisoning. Ann Emerg Med 16:98-101.
16. Davies E, E Knox and I Donaldson (1994) The usefulness of nimodipine, an L-calcium channel antagonist, in the treatment of tinnitus. Br J Audiol 28:125-9.
17. Witsell DL, MT Hannley, S Stinnet et al (2007) Treatment of tinnitus with gabapentin: A pilot study. Otol Neurotol 28:11-5.
18. Bauer CA and TJ Brozoski (2006) Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 116:675-81.
19. Miller B, M Sarantis, SF Traynelis et al (1992) Potentiation of NMDA receptor currents by arachidonic acid. Nature 355:722-5.
20. Peng BG, S Chen and X Lin (2003) Aspirin selectively augmented N-methyl-d-aspartate types of glutamate responses in cultured spiral ganglion neurons of mice. Neurosci Lett 343:21-4.
21. Guitton MJ, R Pujol and JL Puel (2005) m-Chlorophenylpiperazine exacerbates perception of salicylate-induced tinnitus in rats. Eur J Neurosci 22:2675-8.
22. Brozoski TJ, TJ Spires and CA Bauer (2007) Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model. J Assoc Res Otolaryngol 8:105-18.
23. Szczepaniak WS and AR Møller (1995) Evidence of decreased GABAergic influence on temporal integration in the inferior colliculus following acute noise exposure: A study of evoked potentials in the rat. Neurosci Lett 196:77-80.
24. Tartara A, R Manni, CA Galimberti et al (1992) Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. Acta Neurol Scand 86:247-51.
25. Oestreicher E, W Arnold, K Ehrenberger et al (1998) Memantine suppresses the glutamatergic neurotransmission of mammalian inner hair cells. ORL J Otorhinolaryngol Relat Spec 60:18-21.
26. Wallhausser-Franke E, B Cuautle-Heck, G Wenz et al (2006) Scopolamine attenuates tinnitus-related plasticity in the auditory cortex. Neuroreport 17:1487-91.
27. Lobarinas E, G Yang, W Sun et al (2006) Salicylate- and quinine-induced tinnitus and effects of memantine. Acta Otolaryngol Suppl 556:13-9.
28. Wang B, BS Rothberg and R Brenner (2009) Mechanism of increased BK channel activation from a channel mutation that causes epilepsy. J Gen Physiol 133:283-94.
29. Lee US and J Cui (2009) {beta} subunit-specific modulations of BK channel function by a mutation associated with epilepsy and dyskinesia. J Physiol 587:1481-98.
30. Padberg F, P Zwanzger, ME Keck et al (2002) Repetitive transcranial magnetic stimulation (rTMS) in major depression: Relation between efficacy and stimulation intensity. Neuropsychopharmacology 27:638-45.
31. George MS, EM Wassermann, WA Williams et al (1995) Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 6:1853-6.
32. Langguth B, T Kleinjung, E Frank et al (2008) Highfrequency priming stimulation does not enhance the effect of low-frequency rTMS in the treatment of tinnitus. Exp Brain Res 184:587-91.
33. Londero A, B Langguth, D De Ridder et al (2006) Repetitive transcranial magnetic stimulation (rTMS): A new therapeutic approach in subjective tinnitus? Neurophysiol Clin 36:145-55.
34. Kleinjung T, P Eichhammer, B Langguth et al (2005) Longterm effects of repetitive transcranial magnetic stimulation (rTMS) in patients with chronic tinnitus. Otolaryngol Head Neck Surg 132:566-9.
35. Langguth B, P Eichhammer, M Zowe et al (2004) Low frequency repetitive transcranial magnetic stimulation (rTMS) for the treatment of chronic tinnitus - are there long-term effects? Psychiatr Prax 31 Suppl 1:S52-4.